| 699 - 724 |
The synthesis of semipermeable membrane microcapsules using in situ cyanoacrylate ester polymerization
Holl RJ, Chambers RP |
| 725 - 735 |
A new microencapsulation device for controlled membrane and capsule size distributions
Ceausoglu I, Hunkeler D |
| 737 - 752 |
Polymers for biodegradable medical devices XI. Microencapsulation studies: characterization of hydrocortisone-loaded poly-hydroxybutyrate-hydroxyvalerate microspheres
Embleton JK, Tighe BJ |
| 753 - 760 |
Oral controlled release formulation of diclofenac sodium by microencapsulation with ethyl cellulose
Sajeev C, Vinay G, Archna R, Saha RN |
| 761 - 765 |
Microsphere entrapped bee-venom phospholipase A2 retains specific IgE binding capacity: a possible use for oral specific immunotherapy
Guerin V, Dubarry M, Robic D, Brachet F, Rautureau M, Andre C, Bourbouze R, Tome D |
| 767 - 773 |
The effect of solvent removal conditions on performance and release property of protein-loaded microparticles
Lin WJ, Yu CC |
| 775 - 782 |
Characterization of structure and diffusion behaviour of Ca-alginate beads prepared with external or internal calcium sources
Liu XD, Yu WY, Zhang Y, Xue WM, Tu WT, Xiong Y, Ma XJ, Chen Y, Yuan Q |
| 783 - 796 |
The effects of infiltration on protein release from multiphase microspheres fabricated via solvent removal
Godbee J, Weston P, Mathiowitz E |
| 797 - 809 |
Reacetylated chitosan microspheres for controlled delivery of anti-microbial agents to the gastric mucosa
Portero A, Remunan-Lopez C, Criado MT, Alonso MJ |
| 811 - 822 |
Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method
Kim BK, Hwang SJ, Park JB, Park HJ |
